Abstract 2050P
Background
Anorexia is the fourth common symptom seen in half of newly diagnosed cancer patients. It also remains most prevalent and troublesome clinical problem experienced by patients with cancer during and after chemotherapy. Consequently, anorexia adversely influences nutritional status of a patient which further causes a negative impact on quality of life and survival. Various herbs have shown to be having positive effect on treating anorexia. In this study, we analysed the effect of an Ayurveda formulation consisting standardised dry powders of 5 herbs indicated in Ayurveda for treatment of Anorexia.
Methods
We did an assessment of study variables related to anorexia, cachexia and quality of life in a heterogeneous group of stage IV cancer patients (n=45) receiving conventional therapies for cancer and complaining of anorexia. These patients were administered herbal capsule “Ruchir” for treatment of Anorexia. Ruchir is consisting dry herbal powders of Pomegranate (Punica grantum), Black pepper (Piper nigrum), Ginger (Zingiber officinale), Amla (Phyllanthus emblica), Cumin (Cuminum cyminum). Therapy response on Anorexia was assessed using AC (Anorexia/cachexia subscale) and its impact on quality of life was assessed using Functional Assessment of Anorexia / Cachexia Treatment (FAACT). Weight was recorded at each visit (day 0, day 30, day 90, and day 180) using digital weighing scale. Statistical significance was assessed using nonparametric Wilcoxon Signed Ranks Test.
Results
The mean age of study participants were 64.54 (±5.6) years. Significant improvement was observed in Anorexia sub scale score (P < 0.01) and quality of life (P<0.05) as compared to baseline. No significant change was observed in weight. Treatment was well tolerated by all patients.
Conclusions
Herbs used in this study have been shown to have significant effects in reducing anorexia and improving quality of life in a heterogeneous group of cancer patients. This study provides preliminary evidence about effectiveness of herbs in treating Anorexia in cancer patients. Further controlled studies in a homogenous group of patients are warranted to integrate herbs with a standard of care in cancer patients for management of Anorexia.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
Y.N. Bendale: Other, Personal, Ownership Interest: Rasayu Cancer Clinic. All other authors have declared no conflicts of interest.
Resources from the same session
2096P - Morphine titration with intravenous patient-controlled analgesia for severe cancer pain (Mr.TIPS)
Presenter: Seok Jae Huh
Session: Poster session 06
2097P - Incidence, risk factors (RFs) and management of oral mucositis (OM) in patients (pts) treated with a fluoropyrimidines (FP)-based therapy (tp): A retrospective, monocentric experience
Presenter: Fiorella Manfredi
Session: Poster session 06
2098P - The impact of concomitant use of non-opioid analgesics and immune checkpoint inhibitors on survival in lung cancer patients: A Hong Kong population-based cohort study
Presenter: Zheng-Hao Ye
Session: Poster session 06
2099P - The role of ambulatory blood pressure measurement in TKI-induced arterial hypertension diagnosis
Presenter: Elina Khachaturian
Session: Poster session 06
2100P - An exploratory study of the efficacy and safety of hetrombopag in the treatment of thrombocytopenia induced by concurrent or sequential chemoradiotherapy
Presenter: Jun Wang
Session: Poster session 06
2101P - Bleeding Induced by ANtiCAncer drugs (BIANCA) used breast cancer
Presenter: Nicolas Janus
Session: Poster session 06
2102P - Changes in opioid usage after intrathecal morphine pump implantation in patients with terminal cancer (pilot study)
Presenter: Eun Joo Choi
Session: Poster session 06
2103P - Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 a dithiolethione, for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head & neck (H&N) cancer
Presenter: Daniel Osei-Fofie
Session: Poster session 06
2104P - Prevention of taxane chemotherapy induced nail changes and peripheral neuropathy by application of extremity cooling: A prospective single center study with intrapatient comparison
Presenter: Kristen Johnson
Session: Poster session 06
2105P - Prophylactic role of a postbiotic microbiota-stabilizer on abemaciclib-induced diarrhea in breast cancer patients: A pilot application study
Presenter: Rita De Sanctis
Session: Poster session 06